Deadline: 2024-05-29 Status: Open
Descrizione
Planned opening date
29 February 2024ExpectedOutcome:
Outcomes and deliverables
In phase 1:
Validation of the capabilities of metabolic MRI in a pre-clinical context as a diagnostic tool for cancer and neurological diseases and identifying appropriate treatments. This includes benchmarking of the success rate in finding effective cancer therapy within a relevant time frame, treatment responsiveness, recovery time and accuracy of treatment efficacy prediction.
The development of AI/machine learning techniques for cancer imaging and/or neurological imaging, e.g. by analysis of datasets accessible [...]
SE SEI INTERESSATO A QUESTO FINANZIAMENTO CONTATTACI TRAMITE IL MODULO SOTTOSTANTE O REGISTRATI PER ACCEDERE A TUTTE LE INFORMAZIONI E AI PROGETTI DI R&S NELLE TUA AREE DI INTERESSE
Contattaci
Contattaci per maggiori informazioni